Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Vitamin D in Pediatric Type 1 Diabetes
NCT05270343Phase 3Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Jun 2022
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vitamin d in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Residual β-Cell function at 12 months. Status: unknown.
02
Drugs
vitamin d
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05270343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05270343.